Noninvasive Stereotactic Radiation for Refractory Ventricular Tachycardia After Failure of Cardiac
Hannah M Bernstein1, William Leon1, Megan E Daly2
1Division of Cardiovascular Medicine, University of California Davis Medical Center, Sacramento, California, USA.
JACC. Case Reports
|October 10, 2022
Abstract:
Stereotactic body radiation therapy is a novel treatment option for refractory ventricular tachycardia. We present a case of ventricular tachycardia, with epicardial origin located in large inferior infarct scar, that recurred despite treatment with multiple antiarrhythmic drugs, catheter ablation, and cardiac sympathetic denervation. Stereotactic body radiation therapy safely and effectively terminated the arrhythmia. (Level of Difficulty: Advanced.).
Keywords:
4DCT, 4-dimensional computed tomographCMR, cardiac magnetic resonanceCSD, cardiac sympathetic denervationICD, implantable cardioverter-defibrillatorPTV, planning target volumeSBRT, stereotactic body radiation therapyVT, ventricular tachycardiaablationelectrophysiologystereotactic body radiation therapyventricular tachycardia
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
488
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
488
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
65
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
65